Navigation Links
Oxygen Biotherapeutics, Inc. Announces Closing of Offer to Acquire Warrants
Date:7/20/2009

DURHAM, N.C., July 20 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that the company has closed its proposed acquisition of outstanding common stock purchase warrants.

The company acquired and cancelled 52.2 million common stock purchase warrants with an exercise price of $0.247 per share and an additional 18.7 million warrants with an exercise price of $0.245 per share, or a total of 70.9 million warrants. Prior to the transaction there were 121 million warrants outstanding, so the transaction reduces that number to 49.1 million common stock purchase warrants now outstanding. In exchange for the cancelled warrants the company issued to the holders 35.5 million shares of restricted common stock and paid to them $2.8 million in cash.

"The closing of the new financing by the Vatea Fund and the exchange of the warrants marks an enormous leap towards positioning our company for attracting and obtaining future financings that are necessary to support our product development," said Chris Stern, Oxygen Biotherapeutics, Inc. chairman and CEO. "We are glad to have a financing arrangement in place with Vatea Fund that provides the means, after achieving specific milestones, to finance our future growth and development plans. We have significantly improved our working capital position which will enable us to advance the product development programs we have in place and consider a move to a major stock exchange."

The securities purchase agreement with Vatea Fund, assuming all milestones are achieved in a timely manner, provides for Vatea Fund to purchase an additional 60 million shares of the company's stock for a total purchase of 80 million shares for $20 million in cash.

For additional comments by Chris Stern on the investment by Vatea Fund, please see his latest blog and the video posted on the company websi
'/>"/>

SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Home Oxygen Patients and Family Members Visit Capitol Hill to Ask Congress to Protect Medicare Home Oxygen Therapy Benefit
2. Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home
3. National Advocacy Organization Representing Home Oxygen Patients Praises Introduction of Medicare Home Oxygen Therapy Act
4. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
5. Oxygen + MRI might help determine cancer therapy success, researchers find
6. Hummingbird Coaching Partners with Leeza's Place to Help Caregivers “Take Your Oxygen First”
7. Long-term study shows low oxygen levels in prostate tumors can predict recurrence
8. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
9. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
10. Turtle Island Oxygen Trust Sponsors Free Hyperbaric Treatments
11. G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... team has created a new technology for modifying ... travel the body and selectively target cancer and ... devices that monitor and modify human physiology is ... no existing technology enabled bioengineers to build such ... respond in a customized fashion. , "The project ...
(Date:4/17/2014)... 2014) The cause of neuronal death in Parkinson,s ... that neurons may be mistaken for foreign invaders and ... the way autoimmune diseases like type I diabetes, celiac ... study was published April 16, 2014, in Nature ... controversial, idea in Parkinson,s disease; but if true, it ...
(Date:4/17/2014)... EcoHealth Alliance, a nonprofit organization that focuses on conservation ... today examining the current state of knowledge of the ... improved global surveillance strategies to combat the emergence of ... in West Africa that has claimed the lives of ... According to the World Health Organization (WHO), the ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... , Statement of Esta Soler, President, Family Violence Prevention Fund , ... today in Los Angeles in the domestic violence case involving Chris ... like this. Despite what was apparently an extremely violent assault, ... remained a felony, and that Mr. Brown pleaded guilty, taking responsibility ...
... , LOS ANGELES, June 22 Mission Viejo general surgeon ... the newly-elected Chair of the Mutual Protection Trust (MPT) Board ... the Cooperative of American Physicians, Inc. (CAP). Dr. Cobo,s election ... J. Michael Wormley, MD, a Glendora family practitioner who presided ...
... isolated a potent inhibitor of tumor metastasis made by tumor ... treatment. Their findings were published in the online Early Edition ... during the week of June 22. Metastasisthe ... one of the leading causes of death from cancer, and ...
... Tarzana Medical Center on Friday became the first. hospital in the ... Vision RFD - in this case to aid a surgeon in ... a small stroke. , , Zahi E. Nassoura, a board-certified ... saw in the crystal-clear image provided by the Ziehm Vision, approved ...
... misdiagnosis as the likely cause of apparent uptick in melanoma ... released study in the June 2009 British Journal of Dermatology ... United Kingdom has concluded that the much-hyped melanoma "epidemic" is ... attributed the increase in melanoma diagnoses to heightened sensitivity and ...
... The Department of Veterans Affairs (VA) has initiated a large, ... health issues that may affect Operation Enduring Freedom/Operation Iraqi Freedom ... time period. VA,s "National Health Study for a New ... to OEF/OIF and 30,000 comparison Veterans who were not deployed. ...
Cached Medicine News:Health News:Domestic Violence Expert Comments on Chris Brown Plea Deal 2Health News:Dr. Juan Carlos Cobo Newly-Elected Chair of the Mutual Protection Trust Board of Trustees 2Health News:Potent metastasis inhibitor identified 2Health News:Providence Tarzana Surgeon First in U.S. to Use New State-of-the-Art Imaging Tool 2Health News:New Study Says Purported Melanoma Epidemic is Vastly Overstated 2Health News:VA Launches 10-Year Health Study of 60,000 New Veterans 2
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
(Date:1/15/2014)... GARDENS, Fla. , Jan. 15, 2014  In an unprecedented effort ... and TB in ambulances and other transport vehicles, an advanced and ... by rescue personnel for the first time. In ... contact with these deadly pathogens, West Palm Beach ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today ... increased the purchase price of its previously announced "Modified ... to purchase, for cash, up to $65,000,000 aggregate principal ... 2.875% Senior Subordinated Convertible Notes due 2010. , The ...
... DIEGO, Nov. 9, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... 30, 2009. , Arena reported a lower net loss allocable to ... or $0.38 per share, compared to a net loss allocable to ... or $0.76 per share, and a net loss allocable to common ...
Cached Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9
Test for prostatic acid phosphatase...
... you could imagine the ultimate OR, how ... efficiency? Would its control systems be intuitive? ... to quickly adapt to different tasks and ... longer need to imagine this environment. It's ...
... is the world's first Windows ... measuring system. It allows data sharing ... is compatible with Microsoft Office 2000. ... see on the large, sharp 14.1-inch ...
... T-series is a new top-line range of ... and Atrial Fibrillation (AF). Because the T-series ... AF, the treatment of AF is taken ... technology the heart rhythm is monitored continuously ...
Medicine Products: